Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Sahar Ghoflchi, Mohammad Jalili‐Nik, Seyed Isaac Hashemy, Sercan Karav, Hossein Hosseini, Amirhossein Sahebkar · 2026
Read Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials by Sahar Ghoflchi, Mohammad Jalili‐Nik, Seyed Isaac Hashemy, Sercan Karav, Hossein Hosseini, Amirhossein Sahebkar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13239566.txt.
Description
Sahar Ghoflchi and co-authors published a systematic review and meta-analysis in 2026 on nanocurcumin supplements for type 2 diabetes. The nano form aims to fix curcumin's poor absorption. The team pooled randomized trials from three databases, seven in all, covering just over four hundred and fifty patients. Outcomes spanned blood sugar, blood fats, inflammation, and oxidative stress.
Supplements showed no clear effect on fasting glucose, long-term sugar control, blood fats, or an inflammation marker. Oxidative stress markers did move: antioxidant capacity rose and a damage marker fell. The authors say any value likely runs through antioxidant action, and call for larger, longer trials with standard formulations.
Catalog record
| CREATOR | Sahar Ghoflchi, Mohammad Jalili‐Nik, Seyed Isaac Hashemy, Sercan Karav, Hossein Hosseini, Amirhossein Sahebkar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |